ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $301,120 | -84.4% | 16,000 | -78.7% | 0.00% | -83.3% |
| Q1 2021 | $1,935,000 | -61.7% | 75,017 | -20.7% | 0.01% | -62.5% |
| Q4 2020 | $5,058,000 | -21.5% | 94,613 | -39.4% | 0.02% | -30.4% |
| Q3 2020 | $6,445,000 | -43.3% | 156,225 | -33.4% | 0.02% | +4.5% |
| Q2 2020 | $11,374,000 | +64.3% | 234,642 | +43.2% | 0.02% | +29.4% |
| Q1 2020 | $6,922,000 | -46.2% | 163,842 | -45.5% | 0.02% | -34.6% |
| Q4 2019 | $12,860,000 | +122.8% | 300,608 | +87.4% | 0.03% | +136.4% |
| Q3 2019 | $5,772,000 | +234.4% | 160,400 | +159.2% | 0.01% | +37.5% |
| Q2 2017 | $1,726,000 | -69.5% | 61,875 | -62.4% | 0.01% | -69.2% |
| Q1 2017 | $5,656,000 | +15.6% | 164,514 | -3.0% | 0.03% | +13.0% |
| Q4 2016 | $4,891,000 | -7.6% | 169,575 | +1.9% | 0.02% | 0.0% |
| Q3 2016 | $5,291,000 | -1.9% | 166,339 | +0.1% | 0.02% | -4.2% |
| Q2 2016 | $5,396,000 | -39.0% | 166,244 | -47.4% | 0.02% | -40.0% |
| Q1 2016 | $8,840,000 | -22.8% | 316,182 | -1.6% | 0.04% | -20.0% |
| Q4 2015 | $11,454,000 | +5.6% | 321,290 | -2.1% | 0.05% | +13.6% |
| Q3 2015 | $10,848,000 | +57.2% | 328,043 | +99.1% | 0.04% | +57.1% |
| Q2 2015 | $6,899,000 | +28.5% | 164,728 | 0.0% | 0.03% | +27.3% |
| Q1 2015 | $5,368,000 | +272.0% | 164,728 | +262.4% | 0.02% | +266.7% |
| Q4 2014 | $1,443,000 | +37.0% | 45,451 | +6.8% | 0.01% | +20.0% |
| Q3 2014 | $1,053,000 | +8.9% | 42,543 | -0.6% | 0.01% | +25.0% |
| Q2 2014 | $967,000 | -10.8% | 42,816 | -3.9% | 0.00% | -20.0% |
| Q1 2014 | $1,084,000 | +2.7% | 44,538 | +5.5% | 0.01% | 0.0% |
| Q4 2013 | $1,055,000 | – | 42,219 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |